Replies to post #141154 on Rivulet Media Inc (fka RIVU)

[bme]

I did not mean to argue with your post. It's just my thought to share.

[NoQuarter]

I agree with DR. V. The 1$ offering of REGEN shares was one share of REGEN in lieu of 1$ of Debt. However, if REGEN is trying to raise money they will be looking for investors. If we take the consensus that most Biopharm IPO's are opening at 5-15 dollars per share and that debtors were payed at an extremely discounted rate of 1 dollar per share than we can surmise that 'early bird' INVESTORS (not former debtors) will be offered a rate of 3-13 dollars per share. This is dependent upon what is in the pipeline obviously. However seeing REGEN's name out there without BMSN (which was only attached to one of the articles today and conspicuously misspelled) means that they are starting to build a buzz at the ground roots level. Looking forward I do see an all out PR blitz ahead. Some of the possibilities are:
-REGEN opening price and IPO date announcement
-Hema I human trials a go with the FDA
-Entest news (Arthritis study complete?)
-Benitec news concerning DCellvax
-DCellVax human trials outside of the US (Aussie FDA?)
-Big Pharma funding or Grant green light?
-Chance/Community Chest (take a card and be surprised)
GLTYA!!
NoQuarter